Related Experiment Video
Updated: Jun 14, 2026

Isolation of Mesenchymal Stem Cells from Human Alveolar Periosteum and Effects of Vitamin D on Osteogenic Activity of Periosteum-derived Cells
Published on: May 4, 2018
Hypoxia decreases sclerostin expression and increases Wnt signaling in osteoblasts
Damian C Genetos1, Chrisoula A Toupadakis, Leah F Raheja
1Department of Surgical and Radiological Sciences, School of Veterinary Medicine, UC Davis, Davis, California 95616, USA. dgenetos@ucdavis.edu
Abstract:
Mutations in sclerostin function or expression cause sclerosing bone dysplasias, involving decreased antagonism of Wnt/Lrp5 signaling. Conversely, deletion of the VHL tumor suppressor in osteoblasts, which stabilize HIF-alpha isoforms and thereby enables HIF-alpha/beta-driven gene transcription, increases bone mineral content and cross-sectional area compared to wild-type controls. We examined the influence of cellular hypoxia (1% oxygen) upon sclerostin expression and canonical Wnt signaling. Osteoblasts and osteocytes cultured under hypoxia revealed decreased sclerostin transcript and protein, and increased expression and nuclear localization of activated beta-catenin. Similarly, both hypoxia and the hypoxia mimetic DFO increased beta-catenin gene reporter activity. Hypoxia and its mimetics increased expression of the BMP antagonists gremlin and noggin and decreased Smad-1/5/8 phosphorylation. As a partial explanation for the mechanism of regulation of sclerostin by oxygen, MEF2 reporter assays revealed decreased activity. Modulation of VEGF signaling under normoxia or hypoxia revealed no influence upon Sost transcription. These data suggest that hypoxia inhibits sclerostin expression, through enhanced antagonism of BMP signaling independent of VEGF.
Insights
Cellular hypoxia decreases sclerostin expression by inhibiting Wnt/Lrp5 signaling. This finding offers new insights into bone development and sclerosing bone dysplasias, impacting bone mineral density.
Area of Science:
- Biochemistry
- Cell Biology
- Bone Biology
Background:
- Sclerostin mutations cause sclerosing bone dysplasias by reducing Wnt/Lrp5 signaling antagonism.
- VHL tumor suppressor deletion in osteoblasts increases bone mass via HIF-alpha stabilization.
- The role of cellular oxygen levels on sclerostin and Wnt signaling requires further investigation.
Purpose of the Study:
- To investigate the impact of cellular hypoxia on sclerostin expression and canonical Wnt signaling.
- To elucidate the molecular mechanisms linking oxygen levels to sclerostin regulation.
Main Methods:
- Osteoblasts and osteocytes were cultured under hypoxic conditions (1% oxygen).
- Sclerostin transcript and protein levels were measured.
- Beta-catenin expression, nuclear localization, and gene reporter activity were assessed.
- Expression of BMP antagonists (gremlin, noggin) and Smad phosphorylation were analyzed.
- MEF2 and VEGF signaling pathways were modulated and analyzed.
Main Results:
- Hypoxia significantly decreased sclerostin transcript and protein levels in osteoblasts and osteocytes.
- Hypoxia and DFO (hypoxia mimetic) increased beta-catenin expression and nuclear localization.
- Hypoxia increased BMP antagonists (gremlin, noggin) and decreased Smad-1/5/8 phosphorylation.
- MEF2 reporter activity decreased under hypoxia, suggesting a role in sclerostin regulation.
- VEGF signaling modulation did not affect Sost transcription under normoxia or hypoxia.
Conclusions:
- Cellular hypoxia inhibits sclerostin expression.
- This inhibition is mediated through enhanced antagonism of BMP signaling, independently of VEGF.
- Findings suggest a novel regulatory mechanism for sclerostin by oxygen levels, impacting Wnt signaling pathways.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Osteoclasts in Bone Remodeling
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Bone Remodeling
Canonical Wnt Signaling Pathway
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
